These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 658114)

  • 1. Pharmacokinetics and side-effects of clonidine.
    Keränen A; Nykänen S; Taskinen J
    Eur J Clin Pharmacol; 1978 May; 13(2):97-101. PubMed ID: 658114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects.
    Anavekar SN; Jarrott B; Toscano M; Louis WJ
    Eur J Clin Pharmacol; 1982; 23(1):1-5. PubMed ID: 7128667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.
    Frisk-Holmberg M; Edlund PO; Paalzow L
    Br J Clin Pharmacol; 1978 Sep; 6(3):227-32. PubMed ID: 687501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the contribution of clonidine metabolised from alinidine to the cardiovascular effects of alinidine.
    Harron DW; Arndts D; Finch M; Shanks RG
    Br J Clin Pharmacol; 1983 Oct; 16(4):451-5. PubMed ID: 6626441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.
    Wing LM; Reid JL; Davies DS; Neill EA; Tippett P; Dollery CT
    Eur J Clin Pharmacol; 1977 Dec; 12(6):463-9. PubMed ID: 598422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.
    Davies DS; Wing AM; Reid JL; Neill DM; Tippett P; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):593-601. PubMed ID: 870272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man.
    Arndts D; Doevendans J; Kirsten R; Heintz B
    Eur J Clin Pharmacol; 1983; 24(1):21-30. PubMed ID: 6832197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.
    Arndts D; Arndts K
    Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central hypotensive effect of clonidine. Studies in tetraplegic subjects.
    Reid JL; Wing LM; Mathias CJ; Frankel HL; Neill E
    Clin Pharmacol Ther; 1977 Apr; 21(4):375-81. PubMed ID: 321174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology and pharmacokinetics of clonidine.
    Dollery CT; Davies DS; Draffan GH; Dargie HJ; Dean CR; Reid JL; Clare RA; Murray S
    Clin Pharmacol Ther; 1976 Jan; 19(1):11-7. PubMed ID: 1245090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alinidine pharmacokinetics following acute and chronic dosing.
    Harron DW; Arndts D; Shanks RG
    Br J Clin Pharmacol; 1982 Jun; 13(6):821-7. PubMed ID: 7093113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonidine twice daily in hypertension. Effects of two dosage regimens on blood pressure, side-effects and plasma clonidine concentrations.
    Lilja M; Huikuri H; Jounela AJ; Juustila HJ; Paalzow G
    Acta Med Scand; 1983; 214(2):111-7. PubMed ID: 6353878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
    Veith RC; Best JD; Halter JB
    J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of oral sustained release clonidine in humans.
    MacGregor TR; Relihan GL; Keirns JJ
    Arzneimittelforschung; 1985; 35(1A):440-6. PubMed ID: 4039184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of transdermally delivered clonidine.
    MacGregor TR; Matzek KM; Keirns JJ; van Wayjen RG; van den Ende A; van Tol RG
    Clin Pharmacol Ther; 1985 Sep; 38(3):278-84. PubMed ID: 4028622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of plasma clonidine to growth hormone concentrations in children and adolescents.
    Hoffman WH; DiPiro JT; Tackett RL; Arrendale RF; Hahn DA
    J Clin Pharmacol; 1989 Jun; 29(6):538-42. PubMed ID: 2754022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and antihypertensive effects of low dose clonidine during chronic therapy.
    Anavekar SN; Howes LG; Jarrott B; Syrjanen M; Conway EL; Louis WJ
    J Clin Pharmacol; 1989 Apr; 29(4):321-6. PubMed ID: 2723120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidural clonidine or sufentanil for intraoperative and postoperative analgesia.
    De Kock M; Famenne F; Deckers G; Scholtes JL
    Anesth Analg; 1995 Dec; 81(6):1154-62. PubMed ID: 7486097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal syndrome after continuous infusion of clonidine in the normotensive rat.
    Thoolen MJ; Timmermans PB; Van Zwieten PA
    J Pharm Pharmacol; 1981 Apr; 33(4):232-5. PubMed ID: 6115906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties of alinidine in man.
    Wiegand UW; Kasper W; Meinertz T; Stützle U; Jähnchen E
    J Cardiovasc Pharmacol; 1982; 4(1):59-62. PubMed ID: 6176801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.